Abstract
The continued use of topical and systemic antifungal treatment in conventional oral thrush has resulted in multi-resistant Candida albicans. For this reason, new technologies for drug development are a promising strategy in the field of biotechnology. In this way, peptides with the antifungal effects produced by plants, animals, and microorganisms are used as models for developing new dru…